Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

JAK inhibitors show promise for treating various skin diseases.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

NK cells play a role in skin diseases like eczema and psoriasis.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Improving nerve and immune interactions may help heal chronic wounds.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Vitiligo treatments are improving but relapses are common.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Sex hormones influence immune responses and may help treat diseases.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Aptamers can improve wound healing and promote hair growth.

The skin's immune system helps it regenerate and fight infections.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Alopecia areata is hard to treat, but new targeted therapies show promise.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Nanoparticles offer significant benefits over traditional chemotherapy for cancer treatment.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Skin issues can indicate immune system problems.